The first report of an association between administration of sunitinib (oral multitargeted tyrosine-kinase inhibitor recently authorized for treatment of metastatic clear-cell renal carcinoma) and onset of male gynecomastia.
Onset of gynecomastia in a male patient under sunitinib treatment for metastatic clear-cell renal carcinoma
MANFREDINI, Roberto
2009
Abstract
The first report of an association between administration of sunitinib (oral multitargeted tyrosine-kinase inhibitor recently authorized for treatment of metastatic clear-cell renal carcinoma) and onset of male gynecomastia.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in SFERA sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
